Skip to content
S7025Senate2013-2014 SessionSame asA9264

Relates to establishing a pharmacy benefit manager contract appeals process

Sponsor Kemp HannonSD-6+5 co-sponsorsAffects Health
Status
In Senate Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
Kemp Hannon

Senator · Senate District 6

Chair, Health

History

  1. Print number 7025a
  2. Amend and recommit to health
  3. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9264Assembly

Relates to establishing a pharmacy benefit manager contract appeals process

In Assembly Committee · Ways And Means · Sponsor Linda Rosenthal

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S7025A

Title of bill

An act to amend the public health law, in relation to pharmacy benefit managers

Purpose

Requires contracts between pharmacy benefit managers and pharmacies to include a reasonable appeals process.

Summary of provisions

Section one adds a new section 280-a to the Public Health Law.

Section two sets forth the effective date.

Justification

Pharmacy benefit managers (PBMs) are health providers or entities that manage prescription drug program services for healthcare benefit providers. Services include the procurement of prescription drugs to be dispensed to patients or the administration or management of prescription drug benefits.

The Maximum Allowable Cost (MAC) list, is an industry generated price index that lists the maximum amount that a prescription plan will reimburse for generic drugs or multi-source brand names. Since there is no standardization in place or clear methodology on how PBMs generate the MAC list, PBMs have unfettered control to charge their clients prices that may not reflect market demand. This bill would establish a formal appeals process in which a provider could contest a listed product on a MAC list.

Legislative history

New bill.

Fiscal implications

Undetermined.

Effective date

This act shall take effect on the ninetieth day after it shall have become law and shall apply to any contract providing for pharmacy benefit management made or renewed on or after such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.